Quantcast

Latest TARRYTOWN Stories

2014-07-18 08:23:16

TARRYTOWN, N.Y., July 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that in the Phase 3 VIVID-DME trial of EYLEA(®) (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly (2Q4) and EYLEA 2 mg dosed every two months (after 5 initial monthly injections, 2Q8) showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100 (2 years), compared to laser...

2014-06-04 08:29:41

MONTCLAIR, N.J., June 4, 2014 /PRNewswire/ -- There are 116 million people in pain. There are 4,000 pain specialists. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to go around. What can frontline practitioners do to meet the challenges of this growing public health issue? Attend PAINWeekEnd in Tarrytown, convenient to New York, New Jersey, and Connecticut practitioners! The 2014 PAINWeekEnd Regional Conference convenes on Saturday, June...

2014-04-03 16:24:08

Fellowship Program in Collaboration with NASA, Teachers College, Columbia University and STEM Education Leadership Center TARRYTOWN, N.Y., April 3, 2014 /PRNewswire/ -- In a new initiative to promote STEM (Science Technology Engineering Math) education in New York's Hudson Valley, Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced a collaboration with NASA, Teachers College, Columbia University and the STEM Education Leadership Center of Rye, New York to create the Hudson...

2014-03-03 04:22:41

TARRYTOWN, N.Y., March 3, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA(®) (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare (MHLW). "Clinically significant DME is a leading cause of vision loss in the working-age...

2013-11-26 23:20:48

The clinical benefits of using hyperbaric oxygen therapy for breast cancer patients undergoing breast reconstruction has been described in a poster presentation at the 28th Annual Clinical Symposium on Advances in Skin & Wound Care held on October 23-27 at Lake Buena Vista, FL. In threatened mastectomy skin flaps treated at Good Samaritan Hospital, Suffern, NY, over a 4 year, 15 patient period, an 87.5% success rate was realized when hyperbaric oxygen therapy was used, against a...

2013-11-01 23:22:24

The Life Support Technologies group (LST) has successfully taught its 25th “Introduction to Hyperbaric Medicine” course, which is accredited by both the Undersea & Hyperbaric Medical Society (UHMS) and the National Board of Diving & Hyperbaric Medical Technology (NDBHMT). LST provides the 42-hour course 4 times a year at hospital partner facilities. Tarrytown, NY (PRWEB) November 01, 2013 The Life Support Technologies group (LST) has successfully conducted teaching its 25th...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related